A potential cure for the post (long) covid chronic symptoms might have just appeared on the horizon;
For those who like to read the paper;
www.nature.com
For those who like to read the paper;
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID - Nature Communications
A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle that PLpro inhibition may be a viable strategy for preventing and treating long COVID.
www.nature.com